DE3267559D1 - Topical antimicrobial anti-inflammatory compositions - Google Patents

Topical antimicrobial anti-inflammatory compositions

Info

Publication number
DE3267559D1
DE3267559D1 DE8282200731T DE3267559T DE3267559D1 DE 3267559 D1 DE3267559 D1 DE 3267559D1 DE 8282200731 T DE8282200731 T DE 8282200731T DE 3267559 T DE3267559 T DE 3267559T DE 3267559 D1 DE3267559 D1 DE 3267559D1
Authority
DE
Germany
Prior art keywords
topical antimicrobial
inflammatory compositions
antimicrobial anti
inflammatory
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282200731T
Other languages
English (en)
Inventor
Mahdi Bakir Fawzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE3267559D1 publication Critical patent/DE3267559D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE8282200731T 1981-06-23 1982-06-14 Topical antimicrobial anti-inflammatory compositions Expired DE3267559D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,556 US4343798A (en) 1981-06-23 1981-06-23 Topical antimicrobial anti-inflammatory compositions

Publications (1)

Publication Number Publication Date
DE3267559D1 true DE3267559D1 (en) 1986-01-02

Family

ID=23057107

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282200731T Expired DE3267559D1 (en) 1981-06-23 1982-06-14 Topical antimicrobial anti-inflammatory compositions

Country Status (8)

Country Link
US (1) US4343798A (de)
EP (1) EP0068553B1 (de)
JP (1) JPS5841819A (de)
AU (1) AU549201B2 (de)
CA (1) CA1182396A (de)
DE (1) DE3267559D1 (de)
ES (1) ES8308213A1 (de)
NZ (1) NZ201029A (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
JPS59175425A (ja) * 1983-03-25 1984-10-04 Otsuka Pharmaceut Co Ltd 脳卒中予防剤
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
CA1331559C (en) 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1302280C (en) 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5126257A (en) * 1986-11-26 1992-06-30 Cornell Research Foundation Antimicrobial proteins, compositions containing same and uses thereof
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US5171576A (en) * 1987-03-09 1992-12-15 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5000956A (en) * 1987-03-09 1991-03-19 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5049387A (en) * 1987-03-09 1991-09-17 Alza Corporation Inducing skin tolerance to a sensitizing drug
US5077054A (en) * 1987-03-09 1991-12-31 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5118509A (en) * 1987-03-09 1992-06-02 Alza Corporation Inducing skin tolerance to a sensitizing drug
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US4820720A (en) * 1987-08-24 1989-04-11 Alza Corporation Transdermal drug composition with dual permeation enhancers
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5378730A (en) * 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
US5175190A (en) * 1991-02-15 1992-12-29 The University Of British Columbia Medium chain fatty acids of C8-10 for the treatment of skin lesions
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
WO1993023025A1 (en) * 1992-05-13 1993-11-25 Alza Corporation Transdermal administration of oxybutynin
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
JPH08512054A (ja) * 1993-06-25 1996-12-17 アルザ・コーポレーション 経皮系におけるポリ−ｎ−ビニルアミドの含有
KR960704579A (ko) * 1993-09-29 1996-10-09 에드워드 엘. 만델 옥시부티닌용 모노글리세리드/락테이트 에스테르 투과 촉진제(Monoglyceride/lactate Ester Permeation Enhancer for Oxybutynin)
DE69502281T2 (de) * 1994-03-30 1998-11-12 Alza Corp Verminderung der hautreizung während einer iontophoretischen abgabe von medikamenten
US5685872A (en) * 1995-06-07 1997-11-11 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein using amide compositions in absorbent article
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5612045A (en) * 1995-06-07 1997-03-18 Kimberly-Clark Corporation Inhibition of exoprotein in absorbent article
US5618554A (en) * 1995-06-07 1997-04-08 Kimberly-Clark Corporation Inhibition of exoprotein using amine compositions in absorbent article and method thereof
DE19643587A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sterole und Sterolderivate
EP0934078B1 (de) * 1996-10-24 2002-12-18 Alza Corporation Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
US6132762A (en) * 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
US6267984B1 (en) 1997-12-22 2001-07-31 Alza Corporation Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
US6544541B1 (en) 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
EP1269972B1 (de) * 2000-04-07 2005-10-19 Taisho Pharmaceutical Co., Ltd Haarwachstumstimulierende mittel mit verlängerter wirkung
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
GB2364208B (en) 2000-06-30 2004-11-17 Nokia Mobile Phones Ltd Improved data input
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
DE10153023A1 (de) * 2001-10-26 2003-05-15 Beiersdorf Ag Wirkstoffhaltige kosmetische Reinigungsemulsionen
US6472358B1 (en) 2001-11-15 2002-10-29 Ecolab Inc. Acid sanitizing and cleaning compositions containing protonated carboxylic acids
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
US20030206882A1 (en) * 2002-05-03 2003-11-06 Richter Francis L. Fatty acid sanitizer
US20040033255A1 (en) 2002-06-10 2004-02-19 Baker Carl J. Transdermal delivery device disposal system
DE60326354D1 (de) * 2002-08-20 2009-04-09 Euro Celtique Sa Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
US20040156870A1 (en) * 2003-02-11 2004-08-12 Bradley Pharmaceuticals, Inc. Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs
DE10318526A1 (de) * 2003-04-24 2004-11-11 Beiersdorf Ag Reinigungsemulsion mit hohem Fettgehalt
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
JP4696107B2 (ja) * 2004-03-24 2011-06-08 コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ ブクホルジア属に属する植物の抽出物の化粧品および医薬品における使用
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
FR2893845B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US20070184124A1 (en) * 2006-02-07 2007-08-09 Steve Harlan Skin stabilizer preparation
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20120035557A1 (en) 2010-07-16 2012-02-09 Timothy Woodrow Coffindaffer Personal Care Compositions Comprising A Multi-Active System For Down Regulating Cytokines Irritation
JP6050763B2 (ja) 2011-03-03 2016-12-21 デノバメド インク． 抗菌性の化合物／アジュバント化合物および方法
WO2012125913A1 (en) 2011-03-17 2012-09-20 The Trustees Of The University Of Pennsylvania Methods and use of bifunctional enzyme-building clamp-shaped molecules
WO2012125904A1 (en) * 2011-03-17 2012-09-20 The Trustees Of The University Of Pennsylvania Mutation mimicking compounds that bind to the kinase domain of egfr
US20130045248A1 (en) 2011-08-16 2013-02-21 Timothy Woodrow Coffindaffer Personal care compositions comprising an anti-irritation agent
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
LT2854841T (lt) 2012-06-04 2017-06-12 Diamedica Inc. Kalikreino 1 iš žmogaus audinio glikozilinimo izoformos
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
MX2016011842A (es) 2014-03-11 2017-02-02 Promius Pharma Llc Composiciones tópicas de corticosteroides.
JP2020510023A (ja) 2017-03-09 2020-04-02 ダイアメディカ， インコーポレイテッド 組織カリクレイン１の剤形
EP3762376B1 (de) 2018-03-05 2023-03-01 Denovamed Inc. Diphenylsubstituierte thiophen-2-amid-derivate und antimikrobielle pharmazeutische zusammensetzung daraus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA553057A (en) * 1958-02-11 J. Ferlin Henry Production of bactericidal compositions
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt
US4124720A (en) * 1970-11-09 1978-11-07 Wenmaekers Georges E J Therapeutic hydrodispersible emulsion
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
DE2912438A1 (de) * 1979-03-29 1980-10-16 Eckert Theodor Topische verwendung von mittelkettigen fettsaeuren (c tief 6 - c tief 14 ) und alkoholischer loesungsmittel bei der behandlung erythrosquamoeser und papuloeser erkrankungen
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
DE2934090A1 (de) * 1979-08-23 1981-03-12 Miroslav T Dipl Ing Dr Bomar Therapie der hyperkeratotischen hauterkrankungen.

Also Published As

Publication number Publication date
CA1182396A (en) 1985-02-12
NZ201029A (en) 1985-10-11
US4343798A (en) 1982-08-10
ES513340A0 (es) 1983-08-16
AU8503882A (en) 1983-01-06
JPS5841819A (ja) 1983-03-11
AU549201B2 (en) 1986-01-16
EP0068553B1 (de) 1985-11-21
EP0068553A1 (de) 1983-01-05
ES8308213A1 (es) 1983-08-16

Similar Documents

Publication Publication Date Title
DE3267559D1 (en) Topical antimicrobial anti-inflammatory compositions
PH17888A (en) Topical antimicrobial composition
GB2148711B (en) Topical pharmaceutical compositions
NZ205882A (en) Topical anti-inflammatory compositions
DE3373270D1 (en) Topical anti-inflammatory compositions
AU544969B2 (en) Topical pharmaceutical compositions
ZA857530B (en) Antimicrobial compositions
GB8521793D0 (en) Analgesic & anti-inflammatory compositions
GB8519256D0 (en) Analgesic/anti-inflammatory compositions
ZA859066B (en) Gel-form topical antibiotic compositions
GB2110091B (en) Parasiticidal compositions
ZA828267B (en) Microbicidal compositions
GB2110092B (en) Parasiticidal compositions
AU4430685A (en) Topical compositions
AU7970182A (en) Fungicidal compositions
AU9199882A (en) Humus-based fertiliser compositions
ZA822357B (en) Topical pharmaceutical compositions
ZA792562B (en) Anti-inflammatory compositions
GB2110090B (en) Parasiticidal compositions
KE3882A (en) Topical anti-inflammatory compositions
MY8600640A (en) Topical pharmaceutical compositions
IL81538A0 (en) Topical pharmaceutical compositions
GB2098068B (en) Parasiticidal compositions
ZW9281A1 (en) Anti-inflammatory compositions
IL64208A0 (en) Topical pharmaceutical composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee